Camber Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $104M | Buy |
|
|||||
|
2023
Q2 | $64M | Buy |
|
|||||
|
2023
Q1 | $26.6M | Sell |
|
|||||
|
2022
Q4 | $63.8M | Sell |
|
|||||
|
2022
Q3 | $60.5M | Buy |
|
|||||
|
2022
Q2 | $20.7M | Hold |
|
|||||
|
2022
Q1 | $25.8M | Hold |
|
|||||
|
2021
Q4 | $22M | Sell |
|
|||||
|
2021
Q3 | $48.7M | Sell |
|
|||||
|
2021
Q2 | $54.5M | Hold |
|
|||||
|
2021
Q1 | $63.5M | Buy |
|
|||||
|
2020
Q4 | $43.4M | Hold |
|
|||||
|
2020
Q3 | $40.5M | Buy |
|
|||||
|
2020
Q2 | $24.7M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $19.6M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $60M | Buy |
|
|||||
|
2019
Q1 | $54.9M | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $175M | Buy |
|
|||||
|
2017
Q1 | $167M | Buy |
|
|||||
|
2016
Q4 | $171M | Buy |
|
|||||
|
2016
Q3 | $184M | Buy |
|
|||||
|
2016
Q2 | $144M | Buy |
|
|||||
|
2016
Q1 | $120M | Buy |
|
|||||
|
2015
Q4 | $118M | Sell |
|
|||||
|
2015
Q3 | $113M | Buy |
|
|||||
|
2015
Q2 | $103M | Buy |
|
|||||
|
2015
Q1 | $103M | Sell |
|
|||||
|
2014
Q4 | $101M | Hold |
|
|||||
|
2014
Q3 | $94.1M | Hold |
|
|||||
|
2014
Q2 | $91.7M | Buy |
|
|||||
|
2014
Q1 | $87.2M | Sell |
|
|||||
|
2013
Q4 | $80.2M | Hold |
|
|||||
|
2013
Q3 | $75.6M | Buy |
|
|||||
|
2013
Q2 | $29.4M | Buy |
|